Ten-year experience with extended criteria cardiac transplantation

Circulation: Heart Failure

Volumn 6, Issue 6, 2013, Pages 1230-1238

  Samsky, Marc D ^a   Patel, Chetan B ^a,b   Owen, Ashleigh ^a   Schulte, Phillip J ^b   Jentzer, Jacob ^a   Rosenberg, Paul B ^b   Felker, G Michael ^a,b   Milano, Carmelo A ^a   Hernandez, Adrian F ^a,b   Rogers, Joseph G ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Heart failure; Survival; Transplantation

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DONOR; EXTENDED CRITERIA CARDIAC TRANSPLANT PROGRAM; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HEALTH PROGRAM; HEART GRAFT; HEART TRANSPLANTATION; HEMODIALYSIS; HUMAN; INTRAAORTIC BALLOON PUMP; ISCHEMIC CARDIOMYOPATHY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; NEGRO; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; COMPARATIVE STUDY; FOLLOW UP; HEART FAILURE; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL; TIME; TRANSPLANTATION; UNITED STATES; EPIDEMIOLOGY; TRENDS;

HEART FAILURE; SURVIVAL; TRANSPLANTATION;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS; UNITED STATES;

EID: 84892633576     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.113.000296     Document Type: Article

References (23)

1. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report-2011. J Heart Lung Transplant. 2011;30:1078-1094.
2. Zaroff JG, Rosengard BR, Armstrong WF, Babcock WD, D?Alessandro A, Dec GW, Edwards NM, Higgins RS, Jeevanandum V, Kauffman M, Kirklin JK, Large SR, Marelli D, Peterson TS, Ring WS, Robbins RC, Russell SD, Taylor DO, Van Bakel A, Wallwork J, Young JB. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation. 2002;106:836-841.
3. Felker GM, Milano CA, Yager JE, Hernandez AF, Blue L, Higginbotham MB, Lodge AJ, Russell SD. Outcomes with an alternate list strategy for heart transplantation. J Heart Lung Transplant. 2005;24:1781-1786.
4. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
5. Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN III; INTrEPID Investigators. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol. 2007;50:741-747.
6. Laks H, Marelli D, Fonarow GC, Hamilton MA, Ardehali A, Moriguchi JD, Bresson J, Gjertson D, Kobashigawa JA; UCLA Heart Tranplant Group. Use of two recipient lists for adults requiring heart transplantation. J Thorac Cardiovasc Surg. 2003;125:49-59.
7. Laks H, Scholl FG, Drinkwater DC, Blitz A, Hamilton M, Moriguchi J, Fonarow G, Kobashigawa J. The alternate recipient list for heart transplantation: does it work? J Heart Lung Transplant. 1997;16:735-742.
8. Patel J, Kobashigawa JA. Cardiac transplantation: the alternate list and expansion of the donor pool. Curr Opin Cardiol. 2004;19:162-165.
9. Lima B, Rajagopal K, Petersen RP, Shah AS, Soule B, Felker GM, Rogers JG, Lodge AJ, Milano CA. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation. 2006;114(1 suppl):I27-I32.
10. Chen JM, Russo MJ, Hammond KM, Mancini DM, Kherani AR, Fal JM, Mazzeo PA, Pinney SP, Edwards NM, Naka Y. Alternate waiting list strategies for heart transplantation maximize donor organ utilization. Ann Thorac Surg. 2005;80:224-228.
11. Ghali WA, Quan H, Brant R, van Melle G, Norris CM, Faris PD, Galbraith PD, Knudtson ML; APPROACH (Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease) Investigators. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. Jama. 2001;286:1494-1497.
12. Hunt SA. Comment-the REMATCH trial: long-term use of a left ventricular assist device for end-stage heart failure. J Card Fail. 2002;8:59-60.
13. Levy WC, Aaronson KD, Dardas TF, Williams P, Haythe J, Mancini D. Prognostic impact of the addition of peak oxygen consumption to the Seattle Heart Failure Model in a transplant referral population. J Heart Lung Transplant. 2012;31:817-824.
14. Jeevanandam V, Furukawa S, Prendergast TW, Todd BA, Eisen HJ, McClurken JB. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg. 1996;62:1268-1275.
15. Taylor DO, Stehlik J, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, Kucheryavaya AY, Rahmel AO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. J Heart Lung Transplant. 2009;28:1007-1022.
16. Weiss ES, Allen JG, Arnaoutakis GJ, George TJ, Russell SD, Shah AS, Conte JV. Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT). Ann Thorac Surg. 2011;92:914-921; discussion 921.
17. Weiss ES, Nwakanma LU, Patel ND, Yuh DD. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database. J Heart Lung Transplant. 2008;27:184-191.
18. Segovia J, Cosio MD, Barcelo JM, Bueno MG, Pavia PG, Burgos R, Serrano-Fiz S, Garcia-Montero C, Castedo E, Ugarte J, Alonso-Pulpon L. RADIAL: a novel primary graft failure risk score in heart transplantation. J Heart Lung Transplant. 2011;30:644-651.
19. Kilic A, Weiss ES, Yuh DD, Shah AS, Conte JV. Factors associated with 5-year survival in older heart transplant recipients. J Thorac Cardiovasc Surg. 2012;143:468-474.
20. Kilic A, Weiss ES, Allen JG, George TJ, Yuh DD, Shah AS, Conte JV. Should orthotopic heart transplantation using marginal donors be limited to higher volume centers? Ann Thorac Surg. 2012;94:695-702.
21. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM III, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251.
22. Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steidley DE, Ewald GA, Sundareswaran KS, Farrar DJ, Slaughter MS; HeartMate II Clinical Investigators. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail. 2012;5:241-248.
23. Daneshmand MA, Rajagopal K, Lima B, Khorram N, Blue LJ, Lodge AJ, Hernandez AF, Rogers JG, Milano CA. Left ventricular assist device destination therapy versus extended criteria cardiac transplant. Ann Thorac Surg. 2010;89:1205-1209; discussion 1210.